Download Files:
Insulin degludec
$220 – $1,650
Products Details
Product Description
– Insulin degludec is an ultra-long-acting form of insulin used for the research of hyperglycemia caused by type 1 and type 2 dabetes. Insulin degludec shows binding efficiency with an IC50 value of 19.59 nM for insulin receptor. Insulin degludec can be used for the research of type 1 and type 2 diabetes[1][2].
Web ID
– HY-108743
Storage Temperature
– -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light, under nitrogen)
Shipping
– Blue Ice
Applications
– Metabolism-sugar/lipid metabolism
Molecular Formula
– N/A
References
– [1]Bataglini C, et al. Insulin degludec and glutamine dipeptide modify glucose homeostasis and liver metabolism in diabetic mice undergoing insulin-induced hypoglycemia. J Appl Biomed. 2021 Dec;19(4):210-219.|[2]Hartmann T, et al. Effect of the long-acting insulin analogues glargine and degludec on cardiomyocyte cell signalling and function. Cardiovasc Diabetol. 2016 Jul
CAS Number
– 844439-96-9
Molecular Weight
– N/A
Compound Purity
– 99.94
SMILES
– [Insulin degludec]
Clinical Information
– Launched
Research Area
– Endocrinology
Solubility
– 0.1 M HCL : 50 mg/mL (ultrasonic;adjust pH to 2 with 0.1 M HCL)
Target
– Insulin Receptor
Pathway
– Protein Tyrosine Kinase/RTK
Product type
– Peptides
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
